Explore 3 Stock Ideas & Industry Insights Download Free Report

USA Equities Corp

Company price
0.2071 USD -0.06 ( 23.58%)
Last update at 2026-11-18T15:23:00Z
VOLUME
10950
Market Cap
6.01M
P/E
10.00

Momentum Score

…

QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health system lab expert system (QHSLab), designed to function as an extension of a medical practice's existing clinical workflow that supports structured screening, automated documentation, and digital follow-up while minimizing disruption to physicians and staff; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.21
Low
0.23
High
52 Week Price Range
0.08
Low
1.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

USA Equities Corp is a small-cap issuer quoted on the OTCQB for which publicly available corporate descriptions and recent filings are limited, so its core business and operations are not clearly documented. Long-term growth drivers cannot be confirmed from public records; the company may benefit if management executes asset acquisitions, improves disclosure and demonstrates sustainable revenue generation.
Principal risks include low liquidity and thin trading on the OTC market, potential equity dilution, limited audited financial information, and execution or governance risk that could materially affect shareholder value—investors should monitor regulatory filings and company announcements.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.27
Dividend Yield
-
Revenue TTM
3.02M
Revenue Per Share
0.23
Gross Profit TTM
2.04M
Debt / Equity
-
ROE
114.59%
Net Debt
1.57M
ROCE
7.63%
Diluted EPS TTM
0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 0.46M -0.26M -0.47M -1.00M -0.77M
Net income 0.46M -0.26M -0.47M -1.00M -0.77M
Selling general administrative 1.12M 0.79M 0.75M 0.92M 1.05M
Gross profit 1.81M 1.36M 0.79M 0.62M 0.67M
Reconciled depreciation 0.09M 0.15M 0.15M 0.13M 0.04M
Ebit - - - -0.56M -0.50M
Ebitda - - - -0.43M -0.49M
Operating income 0.13M 0.21M -0.24M -0.56M -0.50M
Interest expense 0.24M 0.47M 0.23M 0.43M 0.25M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.24M -0.47M -0.23M -0.43M -0.25M
Total revenue 2.69M 2.13M 1.41M 1.24M 1.41M
Total operating expenses 2.56M 1.93M 1.65M 1.80M 1.92M
Cost of revenue 0.88M 0.77M 0.62M 0.62M 0.74M
Total other income expense net 0.56M 0.00M 0.00M -0.00M -0.02M
Net income from continuing ops 0.46M -0.26M -0.47M -1.00M -0.77M
Net income applicable to common shares - - - -1.00M -0.77M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.17M 1.80M 1.68M 1.96M 2.21M
Intangible assets 1.29M 1.38M 1.53M 1.67M 1.76M
Other current assets 0.02M 0.03M 0.01M 0.01M 0.02M
Total liab 0.55M 2.41M 2.06M 1.88M 1.38M
Total stockholder equity 1.62M -0.61M -0.38M 0.08M 0.82M
Other current liab 0.02M 0.34M 0.20M 0.12M 0.06M
Common stock - - - 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -3.90M -4.33M -3.98M -3.51M -2.52M
Other liab - - - - 0.01M
Cash 0.64M 0.16M 0.05M 0.18M 0.29M
Total current liabilities 0.45M 2.41M 2.06M 1.71M 0.87M
Net debt - 1.57M 1.73M 1.50M 1.01M
Short long term debt 0.11M 1.72M 1.78M 1.50M 0.80M
Other stockholder equity - - - - -0.01M
Total current assets 0.88M 0.42M 0.16M 0.29M 0.45M
Net tangible assets - - - -1.60M -0.94M
Net receivables 0.19M 0.20M 0.07M 0.05M 0.07M
Long term debt 0.10M - - 0.17M 0.50M
Inventory 0.04M 0.04M 0.03M 0.05M 0.07M
Accounts payable 0.33M 0.34M 0.08M 0.09M 0.02M
Non current assets total 1.29M 1.38M 1.53M 1.67M 1.76M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - 0.00M -0.04M -0.15M
Change to liabilities - - - 0.07M -0.13M
Total cashflows from investing activities - - - -0.04M -0.15M
Net borrowings -0.20M -0.04M 0.03M 0.26M 0.76M
Total cash from financing activities 0.30M -0.04M 0.03M 0.28M 0.70M
Change to operating activities - - - 0.07M 0.07M
Net income 0.46M -0.26M -0.47M -1.00M -0.77M
Change in cash 0.48M 0.11M -0.13M -0.11M 0.19M
Begin period cash flow 0.16M 0.05M 0.18M 0.29M 0.09M
End period cash flow 0.64M 0.16M 0.05M 0.18M 0.29M
Total cash from operating activities 0.18M 0.14M -0.16M -0.35M -0.35M
Issuance of capital stock 0.50M 0.00M 0.00M 0.05M 0.03M
Depreciation 0.09M 0.15M 0.15M 0.13M 0.04M
Change to inventory 0.01M -0.02M 0.03M 0.01M 0.03M
Change to account receivables -0.00M -0.13M -0.03M 0.01M -0.01M
Other cashflows from financing activities - - - -0.03M -0.09M
Change to netincome - - - 0.05M 0.26M
Capital expenditures 0.00M 0.00M 0.00M 0.04M 0.15M
Change in working capital 0.17M 0.24M 0.06M 0.16M -0.03M
Stock based compensation - 0.00M 0.01M 0.03M 0.04M
Other non cash items 0.50M 0.02M 0.08M 0.31M 0.35M
Free cash flow 0.18M 0.14M -0.16M -0.39M -0.51M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
USAQ
USA Equities Corp
-0.06
23.58%
0.21 10.00 17.24 1.99 3.09 1.49 6.24
ABT
Abbott Laboratories
-
-%
104.48 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-1.43
1.40%
100.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
0.19
0.06%
318.15 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-0.10
0.22%
47.50 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

USA Equities Corp

QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health system lab expert system (QHSLab), designed to function as an extension of a medical practice's existing clinical workflow that supports structured screening, automated documentation, and digital follow-up while minimizing disruption to physicians and staff; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.

901 Northpoint Parkway, West Palm Beach, FL, United States, 33407

929 379 6503

12

Name Title Year Born
Mr. Troy James Grogan CEO, CFO, Pres & Chairman 1977
Ms. Cyndi Cole CPA, M.B.A. Financial Controller NA
Olivia Giamanco Marketing Director NA
Mr. Troy James Grogan CEO, CFO, President & Chairman 1977
Ms. Olivia Giamanco Marketing Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…